1. Bevans KB, Riley AW, Moon J, Forrest CB. Conceptual and methodological advances in child-reported outcomes measurement. Expert Rev Pharmacoecon Outcomes Res. 2010;10(4):385–96.
2. Forrest CB, Simpson L, Clancy C. Child health services research: challenges and opportunities. JAMA. 1997;277(22):1787–93.
3. Maldonado S. United States perspective. In: Mulberg A, Silber S, van den Anker J, editors. Pediatric drug development: concepts and applications. New Jersey: Wiley; 2009. p. 133–6.
4. The Best Pharmaceuticals for Children Act of 2002. Public Law 107-109, 115 Stat.1408-1424. 2002. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM049874.pdf .
5. The Pedatric Research Equity Act of 2003. Public Law 108-155, 117 Stat.1936-1943. 2003. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM077853.pdf .